Occurence of exophiala dermatitidis in patients with cystic fibrosis in Bonn;Vorkommen von exophiala dermatitidis bei patienten mit zystischer fibrose in Bonn

Atemwegs- und Lungenkrankheiten

Volumn 29, Issue 8, 2003, Pages 373-379

  Horre R ^a,c   Schroteler A ^d   Marklein, G ^d   Breuer, G ^a   Siekmeier, R ^a   Sterzik, B ^a   De Hoog, G S ^b   Schnitzler, N ^a   Schaal, K P ^d  

^a Bundesinst Arzneimittel/Med Prod   (Germany)

^b Zentralburo fur Schimmelkulturen   (Netherlands)

^c Bundesinst Arzneimittel/Med Prod   (Germany)

^d NONE

Author keywords

Cystic fibrosis; Exophiala dermatitidis; Mycosis

Indexed keywords

ADULT; CLINICAL FEATURE; CONFERENCE PAPER; CULTURE MEDIUM; CYSTIC FIBROSIS; DERMATITIS; EXOPHIALA; FEMALE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS; SPUTUM ANALYSIS; SYMPTOM;

EID: 0141483806     PISSN: 03413055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Blaschke-Hellmessen R., I. Lauterbach, K.D. Paul, K. Tintelnot, G. Weissbach: Detection of Exophiala dermatitidis (Kano) De Hoog 1977 in septicemia of a child with acute lymphatic leukaemia and from patients with cystic fibrosis. Mycoses 37 (Suppl. 1), 89-96 (1994).
2. Blaschke-Hellmessen R., K.D. Paul, Y. Jentsch: Klinische Bedeutung, Nachweis und Umweltverhalten der "Schwarzen Hefe" Exophiala dermatitidis. 48. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie, 8.-11.10.1996 in Bonn, Poster 224, Abstractband p. 213 (1996).
3. Blaschke-Hellmessen R., K.D. Paul, K. Ulbrich, Y. Jentsch: Exophiala dermatitidis bei Mukoviszidose. Diagnostik, klinische Bedeutung und Therapie. 29. Wissenschafliche Tagung der Deutschsprachigen Mykologischen Gesellschaft e.V., 7.-10.09. 1997 in Dresden. P 26, Abstractband p. 108 (1995).
4. De Hoog G.S., J. Guarro, J. Gené, M.J. Figueras: Atlas of Clinical Fungi, 2nd. ed. Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili. 51, (2000).
5. De Hoog G.S., G. Haase: Nutritional physiology and selective isolation of Exophiala dermatitidis. Antonie Van Leeuwenhoek 64, 17-26 (1993).
6. Diemert D., D. Kunimoto, C. Sand, R. Rennie: Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis. Scand. J. Infect. Dis. 33, 777-779 (2001).
7. Groll A.H., T.J. Walsh: Uncommon opportunistic fungi: new nosocomial threats. Clin. Microbiol. Infect. 7 (Suppl 2), 8-24 (2001).
8. Haase G., C. Conrad, H. Kentrup, N. Schnitzler: Nachweis von Exophiala dermatitidis-spezifischen Antikörpern bei Patienten mit zystischer Fibrose. 31. Wissenschaftliche Tagung der Deutsch-sprachigen Mykologischen Gesellschaft e.V., 18.-21.09.1997 in Aachen. P 22, Abstractband p. 93 (1997).
9. Haase G., H. Skopnik, T. Groten, G. Kusenbach, H. G. Posselt: Long-term fungal cultures from sputum of patients with cystic fibrosis. Mycoses 34, 373-376 (1991).
10. Haase G., H. Skopnik, G. Kusenbach: Exophiala dermatitidis infection in cystic fibrosis. Lancet 21, 188-189 (1990).
11. Horré R., G.S. De Hoog: Primary cerebral infections by melanized fungi: a review. Stud. Mycol. 45, 176-194 (1999).
12. Horré R., A. Schröteler, G. Marklein, R. Siekmeier, B. Sterzik, N. Schnitzler, G.S. De Hoog, K.P. Schaal: Langzeitkulturen bei Patienten mit zystischer Fibrose zum Nachweis der "schwarzen Hefe" Exophiala dermatitidis. 38. Tagung der Deutschen Gesellschaft für Lungen- und Atemwegsforschung e.V. 5.-6.12.2002 in Bochum. Pneumologie 56, 748 E2 (2002).
13. Hughes W.T., H.K. Kim: Mycoflora in cystic fibrosis: some ecologic aspects of Pseudomonas aeruginosa and Candida albicans. Mycopathologia 50, 261-269 (1973).
14. Kabel, P.J., K.E. Illy, R.A. Holl, A.G. Buiting, R.G. Wintermans: Nosocomial intravascular infection with Exophiala dermatitidis. Lancet 22, 1167-1168 (1994).
15. Koch C., H. Cuppens, M. Rainisio, U. Madessani, H. Harms, M. Hodson, G. Mastella, J. Navarro, B. Strandvik, S. McKenzie: European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr. Pulmonol. 31, 1-12 (2001).
16. Kusenbach G., H. Skopnik, G. Haase, F. Friedrichs, H. Dolmen: Exophiala dermatitidis pneumonia in cystic fibrosis. Eur. J. Pediatr. 151, 344-346 (1992).
17. Matos T., G.S. De Hoog, A.G. De Boer, I. De Crom, G. Haase: High prevalence of the neurotropic Exophiala dermatitidis and related oligotrophic black yeasts in sauna facilities. Mycoses 45, 373-377 (2002).
18. Mouton, J.W., R. Brimicombe, J. Weel, J.F.G.M. Meis, G.S. De Hoog: Exophiala dermatitidis in patients with cystic fibrosis: a survey in the Netherlands. Topic Index 20th EWGCF, Brussels, June 1995 European Cystic Fibrosis Society (ECFS). http://www.ecfsoc.org.
19. No author mentioned: FDA issues warning on injected drugs. ProMED-mail post, a program of the Int Soc for Infect Dis. AP Online 16.11.2002. http://www.promedmail.org.
20. Perfect J.R., W.A. Schell: The new fungal opportunists are coming. Clin. Infect. Dis. 22 (Suppl. 2), 112-118 (1996).
21. Rath P.M., K.D. Muller, H. Dermoumi, R. Ansorg: A comparison of methods of phenotypic and genotypic fingerprinting of Exophiala dermatitidis isolated from sputum samples of patients with cystic fibrosis. J. Med. Microbiol. 46, 757-762 (1997).
22. Schmalreck A.F., P. Tränkle, E. Vanca, R. Blaschke-Hellmessen: Differenzierung und Charakterisierung von humanpathogenen Hefen (Candida albicans, Exophiala dermatitidis) und tierpathogenen Algen (Prototheca spp.) mittels Fourier-Transform-Infrarot-Spektroskopie (FT-IR) im Vergleich zu konventionellen Methoden. Mycoses 41 (Suppl. 1), 71-77 (1998).
23. Woollons A., C.R. Darley, S. Paudian, P. Arnstein, J. Blackee, J. Paul:. Phaeohyphomycosis caused by Exophiala dermatitidis following intraarticular steroid injection. Br. J. Dermatol. 135, 475-477 (1996).